Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 13, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$22.1B
sum of reported positions
Reported positions
660
Changes vs prior quarter
624
41 new · 54 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 354 measured positions in 8 quarters, the typical new or larger position finished +0.0 pts against the S&P 500 and 50% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $19.2B | $22.1B |
| Positions | 673 | 660 |
| Biggest line | — | NVIDIA 6% |
| 2.62M |
| $936M |
| 4.2% |
| 1.69M | $639M | 2.9% |
| 2.6M | $618M | 2.8% |
| 423K | $488M | 2.2% |
| 402K | $482M | 2.2% |
| 658K | $382M | 1.7% |
| 963K | $328M | 1.5% |
| 713K | $309M | 1.4% |
| 843K | $297M | 1.3% |
| 1.16M | $293M | 1.3% |
| 606K | $289M | 1.3% |
| 761K | $229M | 1.0% |
| 644K | $221M | 1.0% |
| 379K | $194M | 0.9% |
| 1.42M | $182M | 0.8% |
| 1.35M | $179M | 0.8% |
| 544K | $178M | 0.8% |
| 2.01M | $176M | 0.8% |
| 347K | $174M | 0.8% |
| 429K | $171M | 0.8% |
| 210K | $159M | 0.7% |
| 271K | $152M | 0.7% |
Microsoft (MSFT)
2.68M → 2.52M shares (−6%)
Micron (MU)
514K → 423K shares (−18%)
Eli Lilly (LLY)
417K → 402K shares (−4%)
Palo Alto Networks (PANW)
1.2M → 963K shares (−20%)
Lam Research (LRCX)
867K → 713K shares (−18%)
Alphabet (GOOGL)
859K → 843K shares (−2%)
Taiwan Semiconductor Manufacturing (TSM)
656K → 606K shares (−8%)
Mastercard (MA)
389K → 379K shares (−3%)
Thermo Fisher Scientific (TMO)
354K → 347K shares (−2%)
McKesson Corporation (MCK)
240K → 210K shares (−12%)
Meta (META)
281K → 271K shares (−4%)
Gilead Sciences (GILD)
1.67M → 1.19M shares (−29%)
GE Vernova (GEV)
131K → 114K shares (−13%)
Marvell Technology (MRVL)
712K → 442K shares (−38%)
Amgen (AMGN)
395K → 363K shares (−8%)
Johnson & Johnson (JNJ)
799K → 510K shares (−36%)
Revolution Medicines (RVMD)
581K → 556K shares (−4%)
Vertex Pharmaceuticals (VRTX)
229K → 200K shares (−13%)
Procter & Gamble (PG)
709K → 656K shares (−7%)
Cisco (CSCO)
872K → 816K shares (−6%)
Morgan Stanley (MS)
462K → 440K shares (−5%)
Credo Technology Group Holding (CRDO)
389K → 327K shares (−16%)
Rockwell Automation (ROK)
182K → 175K shares (−4%)
Keysight Technologies (KEYS)
271K → 228K shares (−16%)
Salesforce (CRM)
588K → 499K shares (−15%)